Dedicare AB (publ)
STO:DEDI

Watchlist Manager
Dedicare AB (publ) Logo
Dedicare AB (publ)
STO:DEDI
Watchlist
Price: 44 SEK -2.98%
Market Cap: 420.8m SEK

Profitability Summary

Dedicare AB (publ)'s profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Dedicare AB (publ)

Revenue
1.5B SEK
Operating Expenses
-1.4B SEK
Operating Income
47.7m SEK
Other Expenses
-7.8m SEK
Net Income
40m SEK

Margins Comparison
Dedicare AB (publ) Competitors

Country Company Market Cap Operating
Margin
Net
Margin
SE
Dedicare AB (publ)
STO:DEDI
420.8m SEK
3%
3%
US
CVS Health Corp
NYSE:CVS
101.5B USD
3%
0%
US
Cigna Corp
NYSE:CI
73.4B USD
4%
2%
US
Cigna Group
XMUN:CGN
63.8B EUR
4%
2%
DE
Fresenius SE & Co KGaA
XETRA:FRE
28.5B EUR
10%
5%
DE
Fresenius Medical Care AG
XMUN:FME
23.4B EUR
7%
4%
US
Laboratory Corporation of America Holdings
NYSE:LH
20.9B USD
10%
6%
US
Quest Diagnostics Inc
NYSE:DGX
19.5B USD
15%
9%
US
Guardant Health Inc
NASDAQ:GH
13.9B USD
-48%
-44%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.8B EUR
7%
4%
US
DaVita Inc
NYSE:DVA
7.9B USD
15%
6%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Dedicare AB (publ) Competitors

Country Company Market Cap ROE ROA ROCE ROIC
SE
Dedicare AB (publ)
STO:DEDI
420.8m SEK
14%
7%
15%
8%
US
CVS Health Corp
NYSE:CVS
101.5B USD
1%
0%
7%
1%
US
Cigna Corp
NYSE:CI
73.4B USD
15%
4%
10%
6%
US
Cigna Group
XMUN:CGN
63.8B EUR
15%
4%
10%
6%
DE
Fresenius SE & Co KGaA
XETRA:FRE
28.5B EUR
6%
3%
7%
4%
DE
Fresenius Medical Care AG
XMUN:FME
23.4B EUR
5%
2%
5%
4%
US
Laboratory Corporation of America Holdings
NYSE:LH
20.9B USD
10%
5%
9%
6%
US
Quest Diagnostics Inc
NYSE:DGX
19.5B USD
14%
6%
11%
9%
US
Guardant Health Inc
NASDAQ:GH
13.9B USD
192%
-28%
-36%
-67%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.8B EUR
5%
2%
5%
4%
US
DaVita Inc
NYSE:DVA
7.9B USD
-834%
4%
13%
10%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less